# Liver Immunosuppression Free Trial

> **NCT02498977** · PHASE4 · TERMINATED · sponsor: **King's College London** · enrollment: 116 (actual)

## Conditions studied

- Transplantation, Liver

## Interventions

- **GENETIC:** Biomarker
- **DRUG:** Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine

## Key facts

- **NCT ID:** NCT02498977
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 116 (ACTUAL)
- **Why stopped:** Primary endpoint not reached.
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02498977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02498977, "Liver Immunosuppression Free Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02498977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*